VEGFA and dopa-responsive dystonia due to sepiapterin reductase deficiency: Based on previous reports and the current study, we suggest that if SRD is observed only at the first presentation, it does not necessarily predict poor visual prognosis because anti-VEGF treatment can alleviate damage to foveal photoreceptors in the outer segment by restoring the ELM barrier and improving macular structure and function [16].